HIM
OGN icon

Hillsdale Investment Management’s Organon & Co OGN Stock Holding History

Hillsdale Investment Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-34,750
Closed -$665K – 648
2024
Q3 		$665K Buy
+34,750
New +$720K 0.05% 328

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hillsdale Investment Management's OGN Position: Q4 2024 in Review

Hillsdale Investment Management sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 34,750 shares — an estimated $665K sold.

Hillsdale Investment Management first reported a position in OGN in Q3 2024 and held it in 1 quarter. The position peaked at $665K in Q3 2024. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Hillsdale Investment Management reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 34,750 Organon & Co shares in Q4 2024, an estimated $665K.
  • Hillsdale Investment Management first reported a position in Organon & Co in Q3 2024 and held it in 1 quarter.
  • Hillsdale Investment Management's Organon & Co position peaked at $665K in Q3 2024.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Hillsdale Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.